help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 29, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0202
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/9/2242    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHO, E.-Y.
Right arrow Articles by KIM, K.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHO, E.-Y.
Right arrow Articles by KIM, K.-M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference

Submitted on April 23, 2007
Accepted on May 24, 2007

Roles of Protein Kinase C and Actin Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor

EUN-YOUNG CHO, DONG-IM CHO, JAE H. PARK, HITOSHI KUROSE, MARC G. CARON, and KYEONG-MAN KIM*

From Department of Pharmacology, College of Pharmacy, Chonnam National University, Kwang-Ju, 500-757 Korea (E.Y.C, D.I.C, K.M.K); Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996, USA (J.H.P); Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, Japan (H.K); Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA (M.G.C.)

* To whom correspondence should be addressed. E-mail: kmkim{at}chonnam.ac.kr.

D3 dopamine receptor (D3R) is expressed mainly in parts of the brain that control the emotional behaviors. It is believed that the improper regulation of D3R is involved in the etiology of Schizophrenia. Desensitization of D3R is weakly associated with GRK/{beta}-arrestin directed internalization. This suggests that there might be an alternative pathway that regulates D3R signaling. This report shows that D3R undergoes robust PKC-dependent sequestration that is accompanied by receptor phosphorylation and the desensitization of signaling. PKC-dependent D3R sequestration, which was enhanced by PKC-{beta} or -{delta}, was dynamin-dependent but independent of GRK, {beta}-arrestin, or caveolin1. Site-directed mutagenesis of all possible phosphorylation sites within the intracellular loops of D3R identified serine residues at positions 229 and 257 as the critical amino acids responsible for PMA-induced D3R phosphorylation, sequestration, and desensitization. In addition, the LxxY endocytosis motif, which is located between residues 252 and 255, was found to play accommodating roles for PMA-induced D3R sequestration. A continuous interaction with the actin binding protein 280 (filamin A), which was previously known to interact with D3R, is required for PMA-induced D3R sequestration. In conclusion, the PKC-dependent but GRK-/{beta}-arrestin-independent phosphorylation of D3R is the main pathway responsible for the sequestration and desensitization of D3R. Filamin A is essential for both the efficient signaling and sequestration of D3R.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society